214 related articles for article (PubMed ID: 31408278)
21. [Interleukin-17-mediated inflammation promotes nonalcoholic fatty liver disease in mice with regulation of M1-type macrophage polarization].
Yang Y; Han CY; Guan QB; Ruan SL
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):916-921. PubMed ID: 30669784
[No Abstract] [Full Text] [Related]
22. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ.
Zhong X; Liu H
J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854
[TBL] [Abstract][Full Text] [Related]
23. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis.
Gong M; Zhuo X; Ma A
Med Sci Monit Basic Res; 2017 Jun; 23():240-249. PubMed ID: 28615615
[TBL] [Abstract][Full Text] [Related]
24. Extracellular vesicular lncRNA FAL1 promotes hepatocellular carcinoma cell proliferation and invasion by inducing macrophage M2 polarization.
Lv S; Wang J; Li L
J Physiol Biochem; 2023 Aug; 79(3):669-682. PubMed ID: 37147492
[TBL] [Abstract][Full Text] [Related]
25. IL-4 Alleviates Ischaemia-Reperfusion Injury by Inducing Kupffer Cells M2 Polarization via STAT6-JMJD3 Pathway after Rat Liver Transplantation.
Deng M; Wang J; Wu H; Wang M; Cao D; Li J; Wu Y; Gong J
Biomed Res Int; 2020; 2020():2953068. PubMed ID: 32258110
[TBL] [Abstract][Full Text] [Related]
26. The Transcription of
Gou Y; Yang D; Tian T; Zhu X; Zhang R; Ren J; Tu D; Luo Y; Miao Y; Zhao H; Wang Y; Wei B
Front Immunol; 2022; 13():725595. PubMed ID: 35371096
[TBL] [Abstract][Full Text] [Related]
27. Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB.
Zhu Y; Ruan S; Shen H; Guan Q; Zhai L; Yang Y
Int Immunopharmacol; 2021 Dec; 101(Pt B):108290. PubMed ID: 34717194
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-206 promotes the recruitment of CD8
Liu N; Wang X; Steer CJ; Song G
Gut; 2022 Aug; 71(8):1642-1655. PubMed ID: 34706869
[TBL] [Abstract][Full Text] [Related]
29. MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization.
Liu Y; Chen H; Yan X; Zhang J; Deng Z; Huang M; Gu J; Zhang J
Cell Commun Signal; 2024 Jan; 22(1):86. PubMed ID: 38291436
[TBL] [Abstract][Full Text] [Related]
30. [Review of macrophage heterogeneity and progression of nonalcoholic fatty liver disease].
Xiao Z; Yang J; Zhao J; Bai J; Qin H; Ji G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Dec; 35(12):1128-1134. PubMed ID: 31894013
[TBL] [Abstract][Full Text] [Related]
31. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
Wang J; Luo Z; Yao T; Li W; Pu J
J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
[TBL] [Abstract][Full Text] [Related]
32. LncRNA SNHG20 silencing inhibits hepatocellular carcinoma progression by sponging miR-5095 from MBD1.
Xu B; Li C; Yang B; Zhou F; Tang K; Wang L; Lu W
Am J Transl Res; 2023; 15(6):4314-4331. PubMed ID: 37434830
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of DNMT1 restores macrophage autophagy and M2 polarization in Western diet-induced nonalcoholic fatty liver disease.
Pant R; Kabeer SW; Sharma S; Kumar V; Patra D; Pal D; Tikoo K
J Biol Chem; 2023 Jun; 299(6):104779. PubMed ID: 37142224
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway.
Chi Y; Gong Z; Xin H; Wang Z; Liu Z
J Transl Med; 2020 Mar; 18(1):126. PubMed ID: 32169080
[TBL] [Abstract][Full Text] [Related]
35. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
[TBL] [Abstract][Full Text] [Related]
36. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
37. E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
González-Romero F; Mestre D; Aurrekoetxea I; O'Rourke CJ; Andersen JB; Woodhoo A; Tamayo-Caro M; Varela-Rey M; Palomo-Irigoyen M; Gómez-Santos B; de Urturi DS; Núñez-García M; García-Rodríguez JL; Fernández-Ares L; Buqué X; Iglesias-Ara A; Bernales I; De Juan VG; Delgado TC; Goikoetxea-Usandizaga N; Lee R; Bhanot S; Delgado I; Perugorria MJ; Errazti G; Mosteiro L; Gaztambide S; Martinez de la Piscina I; Iruzubieta P; Crespo J; Banales JM; Martínez-Chantar ML; Castaño L; Zubiaga AM; Aspichueta P
Cancer Res; 2021 Jun; 81(11):2874-2887. PubMed ID: 33771899
[TBL] [Abstract][Full Text] [Related]
38. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
[TBL] [Abstract][Full Text] [Related]
39. Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide.
Cheong H; Lee SS; Lee JS; Kim J; Kim SW; Lee WJ
J Magn Reson Imaging; 2015 May; 41(5):1218-27. PubMed ID: 24916329
[TBL] [Abstract][Full Text] [Related]
40. Major roles of kupffer cells and macrophages in NAFLD development.
Park SJ; Garcia Diaz J; Um E; Hahn YS
Front Endocrinol (Lausanne); 2023; 14():1150118. PubMed ID: 37274349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
